Annual report [Section 13 and 15(d), not S-K Item 405]

SALES OF COMMON STOCK (Details Narrative)

v3.25.0.1
SALES OF COMMON STOCK (Details Narrative) - USD ($)
12 Months Ended
Dec. 18, 2024
May 21, 2024
Dec. 31, 2024
Dec. 31, 2023
May 31, 2024
Aggregate gross proceeds     $ 40,638,000    
Warrants and rights outstanding     188,038   188,038
Proceeds from sale of stock     4,581,282    
Measurement Input, Price Volatility [Member]          
Warrants and rights outstanding, measurement input 58.51 58.78      
Measurement Input, Risk Free Interest Rate [Member]          
Warrants and rights outstanding, measurement input 4.43 4.53      
Measurement Input, Expected Term [Member]          
Warrants and rights outstanding, term 5 years 5 years      
Common Stock [Member]          
Stock issued, shares     38,749 185,549  
Placement Agents [Member]          
Stock issuance cost paid   $ 1,200,000      
Cash fee, percentage   6.00%      
Placement Agents [Member] | Common Stock [Member]          
Stock issuance cost paid   $ 80,000      
Placement Agents [Member] | Warrant [Member]          
Stock issuance costs incurred   1,544,000      
Cash proceeds from issuance of stock   $ 18,456,000      
Common Stock [Member]          
Stock issued, shares     4,581,282    
Aggregate gross proceeds     $ 4,000    
Common Stock [Member] | Placement Agents [Member]          
Warrants and rights outstanding   61,538      
Warrant [Member] | Placement Agents [Member]          
Sale of stock, description purchase an aggregate of 126,500 shares of Common Stock (the “Warrant Shares”), equal to 5.0% of the number of Shares sold in the offering, at an exercise price per share equal to $11.50, which exercise price is equal to approximately 115% of the price per share of the shares sold in the Offering. The Underwriter’s Warrants have a term of five years, are exercisable at any time and from time to time, in whole or in part, during the five (5) year period commencing on December 19, 2024, the closing date of the Offering, and are exercisable via “cashless exercise” in certain circumstances. purchase an aggregate of 61,538 shares of Common Stock (the “Warrant Shares”), an amount equal to 3.0% of the number of Shares sold in the registered direct offering. The Placement Agents’ Warrants have an exercise price per share equal to $12.19, which is equal to approximately 125% of the price per share of the Shares sold in the Offering. Neither the Placement Agents’ Warrants nor the Warrant Shares have been registered under the Registration Statement or otherwise. The Placement Agents’ Warrants have a term of five years, are exercisable at any time and from time to time, in whole or in part, during the four and one-half (4 ½) year period commencing 180 days from the closing date of the Offering which was May 24, 2024, and are exercisable via “cashless exercise” in certain circumstances.      
Fair value of warrants $ 695,000 $ 331,000      
Securities Purchase Agreement [Member]          
Sale of stock, per share   $ 9.75      
Aggregate gross proceeds   $ 20,000,000      
Securities Purchase Agreement [Member] | Common Stock [Member]          
Stock issued, shares   2,051,282      
Underwriting Agreement [Member]          
Stock issued, shares 2,200,000        
Sale of stock, per share $ 10.00        
Stock issuance cost paid $ 1,771,000        
Cash fee, percentage 7.00%        
Warrants and rights outstanding 330,000        
Proceeds from sale of stock 2,530,000        
Proceeds from sale of stock, total $ 25,300,000        
Reimbursed offering amount 95,000        
Underwriting Agreement [Member] | Warrant [Member]          
Stock issuance cost paid 1,897,000        
Stock issuance costs incurred 2,092,000        
Cash proceeds from issuance of stock $ 23,208,000        
Underwriting Agreement [Member] | Common Stock [Member]          
Warrants and rights outstanding 126,500